Due to ongoing research and ever innovative technologies, Alzheimer’s and other related forms of dementia are being diagnosed earlier than ever before.

– New brain scans are enabling doctors to see inside the brains of people at high risk for Alzheimer’s before clinical symptoms develop. One type of scan uses MRI technology to find beta amyloid, which is a plague-like growth on the brain and thought to cause Alzheimer’s. Beta amyloid is a leading indicator of Alzheimer’s.

– Huge advances in blood-based biomarkers have also made it possible to predict Alzheimer’s before it begins, using a simple blood test. The newest test may be able to predict Alzheimer’s with 100% accuracy a full decade before symptoms occur.

– There is also a new eye test which hopes to predict dementia. While the testing is still in early stages, some research has found that the difference sizes of blood vessels in the eye may actually predict dementia before symptoms, allowing people with the disease to receive care before irreversible brain damage occurs.

All of these advances are crucial to fighting Alzheimer’s. There is no cure for the disease, but researchers are hopeful that these critical developments will shed light on its pathology and create more treatment and prevention methods.

– John D. Miller is the founder/owner of Home Care Partners, LLC, a Massachusetts business providing private duty, personalized in-home assistance and companion care services to those needing help in daily activities and household functions. He can be reached at: (781) 378-2164; email: jdmiller@homecarepartners.biz ; or online at: www.homecarepartnersma.com